Skip to main content

Table 1 Demographic and clinical characteristics for TBI patients

From: Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury

Characteristics

All TBI patients (n = 166)

Moderate TBI (n = 33)

Severe TBI (n = 133)

Demographics

   

 Age (years)

45.8 ± 20.3

49.5 ± 19.7

44.9 ± 20.4

 Male —n (%)

124 (74.7)

23 (69.7)

101 (75.9)

Clinical characteristics

   

 Time to ED (min)

77.6 ± 63.5

74.7 ± 64.8

78.3 ± 63.4

 ISS score

24.4 ± 11.8

18.8 ± 11.5

25.9 ± 11.5

 AIS head

4.1 ± 1.1

3.5 ± 1.2

4.3 ± 1.0

 GCS

5.9 ± 3.0

10.5 ± 1.3

4.7 ± 1.9

Marshall score—n (%)

   

 I

28 (16.9)

11 (33.3)

17 (12.8)

 II

76 (45.8)

16 (48.5)

60 (45.1)

 III

13 (7.8)

1 (3.0)

12 (9.0)

 IV

27 (16.3)

3 (9.1)

24 (18.0)

Evacuated mass lesion

21 (12.6)

2 (6.1)

19 (14.3)

Non-evacuated mass lesion

1 (0.6)

0 (0.0)

1 (0.7)

Pre-injury comorbidities—n (%)

45 (27.1)

14 (42.4)

31 (23.3)

Outcomes

   

 Mortality—n (%)

45 (27.1)

1 (3.0)

44 (33.0)

 Neurosurgery performed—n (%)

47 (28.3)

5 (15.1)

42 (31.6)

 Sepsis/infection—n (%)

42 (25.3)

7 (21.2)

35 (26.3)

 Organ failure—n (%)

18 (10.8)

0 (0.0)

18 (13.5)

 6-month GOSE

4.0 ± 2.5

5.7 ± 2.1

3.6 ± 2.5

  1. Unless otherwise stated, results are expressed as mean ± standard deviation (SD)
  2. Abbreviations: TBI traumatic brain injury, ED emergency department, ISS injury severity score, AIS abbreviated injury scale, GCS Glasgow coma scale, GOSE extended Glasgow outcome scale